Understanding Side Effects: Wegovy vs Mounjaro Breakdown
Wegovy Side Effects vs Mounjaro: Key Mechanism Differences
The most significant difference between Wegovy side effects and Mounjaro side effects stems from their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro uses tirzepatide, which targets both GLP-1 and GIP receptors simultaneously. This dual-action approach means Mounjaro patients may experience different side effect patterns, particularly regarding gastrointestinal tolerance and blood sugar effects. Both treatments require gradual dose escalation to minimise side effects, but the escalation schedules differ significantly.
Wegovy follows a five-step escalation from 0.25mg to 2.4mg maintenance over 16 weeks, allowing your body to adapt gradually to semaglutide. Mounjaro uses six dose levels from 2.5mg up to 15mg, with each step maintained for at least four weeks. The different dose ranges and escalation patterns mean some patients may find one treatment's side effect profile more manageable than the other. Your prescriber at EverydayMeds can assess your medical history and tolerance factors to recommend the most suitable option for your individual circumstances.
Wegovy Side Effects and Pricing: Complete UK Cost Breakdown
Understanding the cost implications alongside potential Wegovy side effects helps you plan your weight management journey effectively. Single Wegovy pens start at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing through £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. These prices include the application of discount codes—new customers use code FIRST40 and returning customers use DOSE25 at checkout. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering your first three months with Stock Available availability.
Mounjaro pricing follows a different structure due to its distinct dosing schedule, and having both options available means you're not locked into one treatment if side effects become problematic. The financial flexibility of switching between treatments, combined with our transparent UK pricing, ensures you can find a sustainable approach to weight management. All prices represent final costs to customers after discount application, with no hidden fees or subscription requirements that might complicate your treatment if you need to adjust due to side effect concerns.
Clinical Evidence: Wegovy Side Effects in STEP Trials
The landmark STEP clinical trials provide comprehensive data on Wegovy side effects, helping you understand what to expect during treatment. In STEP 1, the most common side effects included nausea (44%), diarrhoea (30%), vomiting (24%), and constipation (24%), with most occurring during dose escalation phases and improving over time. The Wilding et al. study published in NEJM 2021 demonstrated that patients taking Wegovy alongside diet and exercise experienced these side effects predominantly in the first 12-20 weeks of treatment.
Importantly, discontinuation rates due to Wegovy side effects were manageable, with approximately 7% of patients stopping treatment compared to 3% on placebo. The trials showed that slower dose escalation and proper patient education significantly reduced side effect severity. Your EverydayMeds prescriber reviews these clinical patterns alongside your personal health profile to optimise your treatment plan and minimise potential adverse reactions.
How Wegovy Works: Understanding Side Effect Origins
Wegovy's mechanism as a GLP-1 receptor agonist explains why certain side effects occur and helps you prepare for your treatment journey. The medication works by mimicking glucagon-like peptide-1, a natural hormone that regulates appetite and blood sugar, primarily targeting receptors in your brain's appetite centres and digestive system. This targeted action slows gastric emptying, which creates lasting fullness but can initially cause nausea or digestive discomfort as your body adapts. The appetite reduction effect occurs through direct signalling to brain regions controlling food intake, which may cause temporary changes in food preferences or meal timing. Understanding these mechanisms helps you recognise that initial Wegovy side effects often represent your body's normal adaptation process rather than concerning adverse reactions. Most patients find that maintaining consistent injection timing, staying well-hydrated, and following the prescribed dose escalation schedule significantly improves tolerance within the first 8-12 weeks of treatment.
Ordering Process: Clinical Assessment for Side Effect Management
EverydayMeds' comprehensive ordering process ensures your Wegovy side effects are properly assessed and monitored from the start of treatment. Our 3-minute online clinical assessment captures your medical history, current medications, previous weight loss attempts, and any history of gastrointestinal conditions that might influence side effect risk. Your prescriber reviews this information within 3 working days (or 24 hours with express service) to determine treatment suitability and provide personalised side effect management guidance. Once approved, your Wegovy pen ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements that preserve medication efficacy. The prescription-only medicine status ensures every patient receives appropriate clinical oversight, with follow-up support available for any side effect concerns that arise during treatment. Our GPhC-registered pharmacy team (#9012878) provides ongoing guidance to help you navigate any challenges and optimise your treatment success.
Storage and Practical Considerations for Wegovy Side Effects
Proper Wegovy storage directly impacts both medication effectiveness and potential side effect management throughout your treatment. Store unopened pens in your fridge at 2-8°C, but once removed, Wegovy remains stable at room temperature below 30°C for up to 6 weeks—significantly longer than Mounjaro's 21-day room temperature limit. This storage flexibility proves valuable if you experience injection site reactions and need to allow the medication to reach room temperature before injection, which can reduce injection discomfort. The FlexTouch pen design allows for precise dosing during the mandatory escalation schedule, and consistent injection timing helps your body adapt to the medication while minimising side effects. Always inject into different sites (thigh, upper arm, or abdomen) to prevent injection site reactions, and maintain the weekly schedule even if you experience mild nausea or digestive discomfort. The 6-week room temperature stability also provides peace of mind during travel or temporary fridge issues, ensuring treatment continuity that supports better side effect management.
Wegovy Side Effects vs Mounjaro: Individual Tolerance Patterns
Patient responses to Wegovy side effects versus Mounjaro side effects vary significantly based on individual physiology, medical history, and lifestyle factors. Some patients find Wegovy's single GLP-1 action easier to tolerate, particularly those with sensitive digestive systems, whilst others prefer Mounjaro's dual GIP/GLP-1 approach for potentially different side effect patterns. The key advantage of choosing EverydayMeds lies in our ability to provide both treatments, allowing medically appropriate switches if initial side effect tolerance proves challenging.
Clinical experience suggests that patients with previous GLP-1 medication experience may have predictable tolerance patterns, whilst treatment-naïve patients benefit from starting with the lower side effect risk profile. Your prescriber considers factors like diabetes history, previous weight loss medication responses, and current gastrointestinal health when recommending between Wegovy and Mounjaro. This personalised approach, combined with our flexible supply options, ensures you receive the most suitable treatment for your individual circumstances rather than being limited to a single option.
Complete Treatment Support: Managing Wegovy Side Effects Long-term
Successful Wegovy side effects management extends beyond the initial prescription to encompass ongoing support throughout your weight management journey. EverydayMeds provides continuous access to clinical guidance, whether you're navigating initial dose escalation challenges or optimising maintenance therapy for sustained results. Our prescription-only medicine protocols ensure regular review opportunities, allowing dose adjustments or treatment modifications based on your individual response patterns. Both Wegovy and Mounjaro remain available through our secure ordering system, with consistent pricing and reliable cold-chain delivery that maintains treatment continuity. The combination of transparent pricing, clinical expertise, and flexible treatment options positions EverydayMeds as your long-term partner in weight management success. Start your clinical assessment today at https://everydaymeds.co.uk/collections/weight-loss, using code FIRST40 for new customers or DOSE25 for returning patients, and take the first step toward finding the right treatment balance for your individual needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
